Delivery Order SPE2DB22D3004-SPE2DB24FPH19
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $16,010.25 firm fixed-price contract is for the delivery of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This $80,412.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,470,416 units of the pharmaceutical product IPOL VIAL 5ML. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of...
- This federal contract award is for the procurement of IPOL VIAL 5ML medical products by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,509.23 delivery order contract has an ultimate completion date of May 18, 2023 and was awarded on May 17, 2023. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563358316 ! IPOL VIAL 5ML. The $10,673.50 delivery order has a completion date of January 19, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and services, including specialty, brand name, generic, and over-the-counter medications, as well as medical supplies, to support DLA Troop Support Medical facilities....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,617.30 fixed-price delivery order (SPE2DB22D2006|SPE2DB25FV6QX) is for the supply of IPOL VIAL 5ML medical products, with a completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,134.70 fixed-price delivery order is for the supply of 4,564,359,523 units of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $21,773.94 fixed-price delivery order is for the provision of IPOL VIAL 5ML medication, with a completion date of July 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,976.00 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through May 23, 2023 and was awarded on May 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,154.50 Firm Fixed Price delivery order contract is for the supply of 4567301266 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for $8,094.78 to provide pharmaceutical products and medical supplies. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver a comprehensive range of medications...